A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
Clinical trial NCT07174310 · RECRUITING
Trial details
- NCT number
- NCT07174310
- Sponsor
- Hoffmann-La Roche
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-24
- Primary completion
- 2029-06-30
- Enrollment
- 900
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.